These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2027387)

  • 1. Peptide binding to empty HLA-B27 molecules of viable human cells.
    Benjamin RJ; Madrigal JA; Parham P
    Nature; 1991 May; 351(6321):74-7. PubMed ID: 2027387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
    López D; Barber DF; Villadangos JA; López de Castro JA
    J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro mutagenesis of HLA-B27. Amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain.
    el-Zaatari FA; Sams KC; Taurog JD
    J Immunol; 1990 Feb; 144(4):1512-7. PubMed ID: 1689355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies.
    Boisgérault F; Tieng V; Stolzenberg MC; Dulphy N; Khalil I; Tamouza R; Charron D; Toubert A
    J Clin Invest; 1996 Dec; 98(12):2764-70. PubMed ID: 8981922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal antibody that recognizes HLA-B27 in the context of peptides.
    Wang J; Yu DT; Fukazawa T; Kellner H; Wen J; Cheng XK; Roth G; Williams KM; Raybourne RB
    J Immunol; 1994 Feb; 152(3):1197-205. PubMed ID: 8301124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal heterogeneity in LFA-3 and ICAM-1 requirement for lysis by alloreactive T lymphocytes.
    Galocha B; López D; López de Castro JA
    J Immunol; 1993 Mar; 150(5):1653-62. PubMed ID: 7679690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overlapping peptide-binding specificities of HLA-B27 and B39: evidence for a role of peptide supermotif in the pathogenesis of spondylarthropathies.
    Sobao Y; Tsuchiya N; Takiguchi M; Tokunaga K
    Arthritis Rheum; 1999 Jan; 42(1):175-81. PubMed ID: 9920028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-B27: a registry of constitutive peptide ligands.
    Lopez de Castro JA; Alvarez I; Marcilla M; Paradela A; Ramos M; Sesma L; Vázquez M
    Tissue Antigens; 2004 May; 63(5):424-45. PubMed ID: 15104674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of two chemically modified peptide epitopes for the class I MHC protein HLA-B*2705.
    Jones MA; Hislop AD; Snaith JS
    Org Biomol Chem; 2006 Oct; 4(20):3769-77. PubMed ID: 17024283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-B27-restricted CD8+ T cell response to cartilage-derived self peptides in ankylosing spondylitis.
    Atagunduz P; Appel H; Kuon W; Wu P; Thiel A; Kloetzel PM; Sieper J
    Arthritis Rheum; 2005 Mar; 52(3):892-901. PubMed ID: 15751060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring myelin basic protein for HLA class I-binding sequences.
    Tanigaki N; Fruci D; Groome N; Butler RH; Londei M; Tosi R
    Eur J Immunol; 1994 Sep; 24(9):2196-202. PubMed ID: 7522167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of labelled influenza matrix peptide to HLA DR in living B lymphoid cells.
    Ceppellini R; Frumento G; Ferrara GB; Tosi R; Chersi A; Pernis B
    Nature; 1989 Jun; 339(6223):392-4. PubMed ID: 2786148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific binding of antigenic peptides to cell-associated MHC class I molecules.
    Luescher IF; Romero P; Cerottini JC; Maryanski JL
    Nature; 1991 May; 351(6321):72-4. PubMed ID: 2027386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
    Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L
    J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual topology of an HLA-B27 allospecific T cell epitope lacking peptide specificity.
    Villadangos JA; Galocha B; López de Castro JA
    J Immunol; 1994 Mar; 152(5):2317-23. PubMed ID: 7510742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong memory CD8+ T cell responses against immunodominant and three new subdominant HLA-B27-restricted influenza A CTL epitopes following secondary infection of HLA-B27 transgenic mice.
    Cheuk E; Chamberlain JW
    Cell Immunol; 2005 Apr; 234(2):110-23. PubMed ID: 16054612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope.
    Nietfield W; Bauer M; Fevrier M; Maier R; Holzwarth B; Frank R; Maier B; Riviere Y; Meyerhans A
    J Immunol; 1995 Mar; 154(5):2189-97. PubMed ID: 7868892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on activities of invariant chain peptides on releasing or exchanging of antigenic peptides at human leukocyte antigen-DR1.
    Xu M; Jackson R; Adams S; Humphreys RE
    Arzneimittelforschung; 1999 Sep; 49(9):791-9. PubMed ID: 10514908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies against an HLA-B27-derived peptide react with an epitope present on bacterial proteins.
    Raybourne RB; Williams KM
    J Immunol; 1990 Oct; 145(8):2539-44. PubMed ID: 1698856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The association of HLA-B27 binding peptide and spondylarthropathies].
    Huang F; Yü D
    Zhonghua Yi Xue Za Zhi; 1998 May; 78(5):385-7. PubMed ID: 10923447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.